SYNERGISTIC EFFECTS OF URSOLIC ACID COMPLEXES WITH COPPER, SELENIUM, AND ZINC: A NOVEL APPROACH TO RHEUMATOID ARTHRITIS MANAGEMENT

Main Article Content

Farhana Ayub
Abdul Khaliq Naveed
Adnan Jehangir

Keywords

Ursolic acid, Rheumatoid arthritis, Trace elements

Abstract

This study aims to investigate novel compounds that join together trace elements copper (Cu) and selenium (Se) both in the presence of the known bioactive compound, ursolic acid (UA), applied with buffered zinc chloride for anti-inflammation and immunomodulation. The study uses Freund’s complete adjuvant (FCA) such as an arthritic rat model to assess the ameliorative role of UA+Cu, UA+Se, and UA+Zn against both individual elements and lornoxicam (LX), the drug of choice. Using reverse transcriptase polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA), the results show that UA complexes markedly reduced pro-inflammatory cytokines of TNF-α and NFκB, whilst upregulated anti-inflammatory markers of IL-4 and IL-10. Moreover, UA combinations significantly decreased levels of serum nitric oxide (NO), cyclooxygenase-2 (COX-2), and lipoxygenase (LOX). In contrast, UA complexes showed no evidence for nephrotoxic or hepatotoxic effects presenting a safe treatment option against RA compared to standard therapies. The synthetic efficacy of UA with trace elements TE in a retarding RA sign is revealed ever based on the current study. It may have scientific guidance for future clinical translation.

Abstract 137 | PDF Downloads 34

References

1. Abbas, A. B., & Lichtman, A. H. (2021). Basic immunology: Functions and disorders of the immune system (6th ed.). Elsevier.
2. Choy, E. H., & Panayi, G. S. (2001). Cytokine pathways and joint inflammation in rheumatoid arthritis. New England Journal of Medicine, 344(12), 907–916. https://doi.org/10.1056/NEJM200103223441207
3. Firestein, G. S., & McInnes, I. B. (2017). Immunopathogenesis of rheumatoid arthritis. Immunity, 46(2), 183–196. https://doi.org/10.1016/j.immuni.2017.02.006
4. Kremer, J. M. (2006). The mechanisms of action of biologic agents in the treatment of rheumatoid arthritis. Journal of Clinical Rheumatology, 12(4 Suppl), S1–S2. https://doi.org/10.1097/01.rhu.0000221811.14101.4b
5. Libby, P., Ridker, P. M., & Maseri, A. (2002). Inflammation and atherosclerosis. Circulation, 105(9), 1135–1143. https://doi.org/10.1161/hc0902.104353
6. Mirsaeidi, M., Motahari, H., & Taghizadeh, S. (2021). Potential role of natural compounds in rheumatoid arthritis: A focus on ursolic acid. Frontiers in Pharmacology, 12, 648843. https://doi.org/10.3389/fphar.2021.648843
7. Rahman, M. M., Bhattacharya, P., & Halder, S. K. (2017). Trace elements as immunomodulators in rheumatoid arthritis. Environmental Science and Pollution Research, 24(12), 11021–11036. https://doi.org/10.1007/s11356-017-8839-3
8. Smolen, J. S., Aletaha, D., & McInnes, I. B. (2016). Rheumatoid arthritis. The Lancet, 388(10055), 2023–2038. https://doi.org/10.1016/S0140-6736(16)30173-8

9. Turner, M. D., Nedjai, B., Hurst, T., & Pennington, D. J. (2014). Cytokines and chemokines: At the crossroads of cell signaling and inflammatory disease. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1843(11), 2563–2582. https://doi.org/10.1016/j.bbamcr.2014.05.014
10. Weiss, G., & Schett, G. (2011). Anemia in inflammatory rheumatic diseases. Nature Reviews Rheumatology, 7(4), 205–215. https://doi.org/10.1038/nrrheum.2011.1
11. Aletaha, D., & Smolen, J. S. (2018). Diagnosis and management of rheumatoid arthritis: A review. JAMA, 320(13), 1360–1372. https://doi.org/10.1001/jama.2018.13103
12. Ali, T., Haider, S., & Ahmad, S. (2019). Trace elements and their effect on inflammation: New insights. Biological Trace Element Research, 190(1), 2–9. https://doi.org/10.1007/s12011-018-1566-4
13. Ballantyne, C. M., Hoogeveen, R. C., & Bang, H. (2005). Novel risk markers for coronary disease: The interrelationships of C-reactive protein, fibrinogen, and the leukocyte count. Arteriosclerosis, Thrombosis, and Vascular Biology, 25(2), 112–117. https://doi.org/10.1161/01.ATV.0000150041.81839.58
14. Berenbaum, F. (2013). Oxidative stress and inflammation in osteoarthritis. Current Opinion in Rheumatology, 25(1), 58–63. https://doi.org/10.1097/BOR.0b013e32835a00a6
15. Feldmann, M., & Maini, R. N. (2001). Anti-TNF alpha therapy of rheumatoid arthritis: What have we learned? Annual Review of Immunology, 19(1), 163–196. https://doi.org/10.1146/annurev.immunol.19.1.163
16. Grassi, W., De Angelis, R., Lamanna, G., & Cervini, C. (1998). The clinical features of rheumatoid arthritis. European Journal of Radiology, 27(Suppl 1), S18–S24. https://doi.org/10.1016/s0720-048x(98)00023-1
17. Nguyen, U. S. D. T., Zhang, Y., Lu, N., & Felson, D. T. (2014). Rheumatoid arthritis and mortality: A systematic review and meta-analysis. Arthritis Care & Research, 66(5), 691– 698. https://doi.org/10.1002/acr.22291
18. Pan, M. H., & Ho, C. T. (2008). Chemopreventive effects of natural dietary compounds on cancer development. Chemical Society Reviews, 37(11), 2558–2574. https://doi.org/10.1039/B801558A
19. Shalaby, A. A., Al-Massry, H., & Salama, A. (2020). Selenium's role in inflammatory diseases: Therapeutic effects and molecular mechanisms. Frontiers in Pharmacology, 11, 1276. https://doi.org/10.3389/fphar.2020.01276
20. Xiao, X., Yang, M., & Sun, D. (2020). The protective roles of ursolic acid in inflammation: A molecular perspective. Journal of Molecular Medicine, 98(3), 233–245. https://doi.org/10.1007/s00109-020-01916-y